APA (7th ed.) Citation

Suenaga M, Mizunuma N, Matsusaka S, Shinozaki E, Ozaka M, Ogura M, . . . Yamaguchi T. (2015). A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer. Dove Medical Press.

Chicago Style (17th ed.) Citation

Suenaga M, Mizunuma N, Matsusaka S, Shinozaki E, Ozaka M, Ogura M, Chin K, and Yamaguchi T. A Phase I/II Study of Biweekly Capecitabine and Irinotecan Plus Bevacizumab as Second-line Chemotherapy in Patients with Metastatic Colorectal Cancer. Dove Medical Press, 2015.

MLA (9th ed.) Citation

Suenaga M, et al. A Phase I/II Study of Biweekly Capecitabine and Irinotecan Plus Bevacizumab as Second-line Chemotherapy in Patients with Metastatic Colorectal Cancer. Dove Medical Press, 2015.